Here are relevant reports on : immuno-oncology-market
-
Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021
This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%. Major players in the medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).
- Published: May 2016
- Price: $ 4950
- TOC Available:
-
Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End User (Pharma & Biotech) & Region - Global Forecasts to 2025
The global oxidative stress assay market growth is primed to transition from USD 836 million in 2020 to USD 1,326 million by 2025, showcasing a strong CAGR of 9.7%. Growth in the oxidative stress assay market is attributed to factors such as the biopharmaceutical industry and increasing public-sector funding for academic research.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Occlusion Devices Market by Product (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End User - Global Forecasts to 2023
The global occlusion devices market is projected to reach USD 3.55 Billion by 2023, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).
- Published: April 2018
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Europe Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Europe epigenetics market, valued at USD 0.57 billion in 2024, stood at USD 0.63 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 1.22 billion by the end of the period. Growth is supported by a well-funded life sciences ecosystem, with rising oncology and precision medicine programs that increasingly rely on DNA methylation and chromatin profiling for biomarker discovery and translational research.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Hemato Oncology Testing Market by Product & Services (Services, Assay Kits), Cancer (Leukemia (Acute Myeloid, Acute Lymphocytic), Lymphoma (Non-Hodgkin, Hodgkin), Technology (PCR, NGS), End User & Region - Global Forecast to 2027
The global hemato oncology testing market growth is primed to transition from $2.9 billion in 2022 to $5.6 billion by 2027, showcasing a strong CAGR of 14.2%. The growth in this market is attributed to the increasing number of the hematologic cancer patients as these patient require the regular monitoring and the diagnostic testing during the treatment.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Asia Pacific Electrosurgery Market by Product (Instruments, Accessories, Generators, Smoke Evacuation Systems), Surgery (Cardiovascular, Orthopedic, Cosmetic, Oncology), End User (Hospitals, Ambulatory Surgical Centers) - Regional Forecast to 2031
The Asia Pacific Electrosurgery market, valued at USD 1.55 billion in 2024, stood at USD 1.70 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2025 to 2031, culminating in a forecasted valuation of USD 2.69 billion by the end of the period. This is due to rapid technological advancements in electrosurgical instruments and rising demand for minimally invasive procedures.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Chemiluminescence Immunoassay Market by Product (Instruments, Consumables), Technology (CLEIA, ECLI, Microparticle CLIA), Sample Type (Blood, Saliva), Application (Oncology, Cardiology), End User (Hospital, Clinical Laboratory) - Global Forecast to 2031
The Chemiluminescence Immunoassay market, valued at US$10.89 billion in 2025, stood at US$11.58 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of US$16.39 billion by the end of the period. The chemiluminescence immunoassay (CLIA) market is experiencing rapid growth because increasing rates of chronic and infectious diseases create a need for precise diagnostic tests.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
